Course Detail

The quality of healthcare services in the United States has gained recent attention, driven by concerns over poor outcomes, rising costs, poorly aligned payment incentives, and wide variations in care. Various stakeholders such as healthcare providers, researchers, advocacy groups, government agencies, and private industry are working in collaboration to improve healthcare quality. This course will acquaint the learner with who these stakeholders are and their roles in the healthcare quality improvement cycle, the collaborative processes comprising measure development and implementation, and the use of evidence in continuous healthcare quality improvement. Types of quality measures and the various healthcare quality improvement programs being implemented will be discussed in the context of various healthcare settings.

This course is best taken in conjunction with Quality Measurement for the Pharmaceutical Industry.

Registration Fees

	Registration Fee
NPC Members	$149
Government, Academia, Non-Profit	$149
Corporate	$199

Learning Objectives
Participants in the program can expect to achieve the following learning objectives:

1. Define healthcare system quality;
2. Identify four (4) key stakeholders in healthcare quality and align the stakeholder with their roles in the continuous quality improvement cycle;
3. Provide accurate examples of three (3) types of quality measures;
4. Sequence the steps in quality measure development and describe quality measure evaluation criteria that leads to measure endorsement; and
5. Identify and categorize the various CMS healthcare quality improvement programs and explain how such public programs are drivers of quality in the private sector.

Instructors:

• Eleanor Perfetto, PhD, MS, Program Director, Professor of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy
• Matthew Pickering, PharmD, Postdoctoral Fellow, Pharmaceutical Health Services Research, University of Maryland School of Pharmacy

Contributors and Advisers:

• Alicia DeStefano, MS, RN, CPHQ, Merck
• Carol Alter, MD, AstraZeneca
• Christopher Dezii, RN, MBA, CPHQ, Bristol-Myers Squibb
• Nancy Witkowski, RN, BSN, CCM, CCP, Boehringer Ingelheim
• Terry Livingston, PharmD, Biogen Idec
• Patricia Marchlowska, RN, BSM, Lilly
• Kathy Gans-Brangs, PhD, AstraZeneca

Program Contributors and Advisers/Conflict of Interest Disclosure
It is the policy of the University of Maryland School of Pharmacy Office of Continuing Pharmacy Education to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, all persons in a position to control activity content of continuing pharmacy education activities must disclose their financial relationships with commercial interests relevant to the content of the CPE activity. No Conflicts of interest were identified by the Office of Continuing Pharmacy Education. Disclosures of the faculty and planning committee members are noted for all learners in the designated section of each educational module.

CE: 1.75 Contact Hours
UAN: 0025-0000-15-131-H04-P
Expiration Date: 8/15/2018
Program Number: KE-CN-NPC-001

Questions? Call or Email us at 410-706-3381 or [email protected]

Click for additional information